News

Patient-related factors are key to nevus suspiciousness

Publish date: April 26, 2016

 

EXPERT ANALYSIS FROM SDEF HAWAII DERMATOLOGY SEMINAR

References

He reported having no financial conflicts regarding his presentation. SDEF and this news organization are owned by the same parent company.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Does sharing genetic risk change behavior?
MDedge Dermatology
Tools for Diagnosing Skin Cancer Earlier: Report From the AAD Meeting
MDedge Dermatology
Intralesional interferon excels for challenging basal cell carcinomas
MDedge Dermatology
Nevi, Melanoma, and the Ongoing Argument on Atypia
MDedge Dermatology
Guidelines highlight revolution in advanced melanoma therapies
MDedge Dermatology
FDA Proposes New Rule to Ban Use of Indoor Tanning Devices by Minors
MDedge Dermatology
For BCC, consider curettage only
MDedge Dermatology
Study found long-term benefit of nivolumab for advanced melanoma patients
MDedge Dermatology
Pembrolizumab: 33% response rate in advanced melanoma
MDedge Dermatology
Merkel cell carcinoma responds to first-line pembrolizumab
MDedge Dermatology